High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy-Reference-Cited by-同舟云学术

High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy

Published:2004-11 Issue:5 Volume:24 Page:433-438
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Branca Giovanna,Spanu Teresa,Cammarota Giovanni,Schito Anna Maria,Gasbarrini Antonio,Gasbarrini Giovanni Battista,Fadda Giovanni

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference43 articles.

1. European Helicobacter Study Group. Current European concepts in the management of Helicobacter pylori infections, The Maastricht Consensus Report. Gut 1997;41:8–13.

2. Malfertheiner P, Mégraud F, O’Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G. European Helicobacter pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167–80.

3. Therapy of Helicobacter pylori: current status and issues;Graham;Gastroenterology,2000

4. Antibiotic resistance in Helicobacter pylori: implications for therapy;Graham;Gastroenterology,1998

5. Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance;Buckley;Dign. Dis. Sci.,1997

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Helicobacter pylori eradication with high-dose proton pump inhibitor-amoxicillin dual therapy: A systematic review and meta-analysis;International Journal of Antimicrobial Agents;2024-06

2. Curcumin clarithromycin nano-form a promising agent to fight Helicobacter pylori infections;World Journal of Microbiology and Biotechnology;2023-09-29

3. Antimicrobial Resistance in Helicobacter and Campylobacter;Antimicrobial Drug Resistance;2017

4. Helicobacter pylori antimicrobial resistance rates in the central region of Portugal;Clinical Microbiology and Infection;2014-11

5. Choosing Optimal Firstline Helicobacter pylori Therapy: a View from a Region with High Rates of Antibiotic Resistance;Current Pharmaceutical Design;2014-07-24